Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes
Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the “Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus” trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular …
Read more on News-Medical-Net
Related posts:
- ~~What natural supplements can I take to for type 2 diabetes?
- “What foods should I avoid if I am diabetic?” “You can reverse diabetes type 2″
- controlling type 2 diabetes naturally
- Learn How to Eat Properly If You Have Type 2 Diabetes
- Is there a natural remedy to erectile dysfunction due to Type 1 Diabetes?